FCCC LOGO Faculty Publications
Gradishar WJ , Anderson BO , Balassanian R , Blair SL , Burstein HJ , Cyr A , Elias AD , Farrar WB , Forero A , Giordano SH , Goetz MP , Goldstein LJ , Isakoff SJ , Lyons J , Marcom PK , Mayer IA , McCormick B , Moran MS , O'Regan RM , Patel SA , Pierce LJ , Reed EC , Salerno KE , Schwartzberg LS , Sitapati A , Smith KL , Smith ML , Soliman H , Somlo G , Telli ML , Ward JH , Kumar R , Shead DA
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw. 2018 Mar;16(3) :310-320
Back to previous list
Abstract
Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer. This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.
Notes
Gradishar, William J. Anderson, Benjamin O. Balassanian, Ron Blair, Sarah L. Burstein, Harold J. Cyr, Amy Elias, Anthony D. Farrar, William B. Forero, Andres Giordano, Sharon H. Goetz, Matthew P. Goldstein, Lori J. Isakoff, Steven J. Lyons, Janice Marcom, P. Kelly Mayer, Ingrid A. McCormick, Beryl Moran, Meena S. O'Regan, Ruth M. Patel, Sameer A. Pierce, Lori J. Reed, Elizabeth C. Salerno, Kilian E. Schwartzberg, Lee S. Sitapati, Amy Smith, Karen Lisa Smith, Mary Lou Soliman, Hatem Somlo, George Telli, Melinda L. Ward, John H. Kumar, Rashmi Shead, Dorothy A. 1540-1413 J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. doi: 10.6004/jnccn.2018.0012.